🔎 Trials Near Me

Home › Castration-Resistant Prostatic Cancer › Michigan

Castration-Resistant Prostatic Cancer clinical trials in Michigan

7 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in Michigan.

Cities in Michigan

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Profound Research LLC at Cancer and Leukemia Center, Sterling Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • University of Michigan Health System, Ann Arbor
  • Henry Ford Cancer Detroit, Detroit
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  • University of Michigan ( Site 0021), Ann Arbor
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06863272

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06242470

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

  • BAMF Health, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · Men · Updated May 6, 2026 · NCT04868604

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

  • Barbara Ann Karmanos Cancer Institute, Detroit
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Apr 13, 2026 · NCT06190899

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.